{"id":"https://genegraph.clinicalgenome.org/r/dffa78c4-fc5f-4895-bc34-5d037c53aef1v2.0","type":"EvidenceStrengthAssertion","dc:description":"There is a definitive association between alteration of the MAP2K1 gene and cardiofaciocutaneous syndrome (CFC). The maximum amount of scorable genetic evidence has been published showing de novo as well as non-de novo variants occur in MAP2K1 in patients with CFC (Cizmarova et al., 2016; Dentici et al., 2009; Gripp et al., 2007; Rodriguez-Viciana, Tetsu, et al., 2006). The MAP2K1 gene is also located in the Ras/MAPK pathway, which is associated with the CFC phenotype (Aoki et al., 2016; Rauen, 2013). Of note, MAP2K1 is classified as Limited in association with Noonan syndrome (NS) and NS with multiple lentigines and as Disputed in association with Costello syndrome. The ClinGen RASopathy Expert Panel found no evidence associating MAP2K1 with NS-like disorder with loose anagen hair. This curation was approved by the ClinGen RASopathy Gene Curation Expert Panel on 5/29/18 (SOP Version 5).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/dffa78c4-fc5f-4895-bc34-5d037c53aef1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2021-03-10T15:26:11.115Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2018-05-29T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08184684-12d9-4e7b-a69f-93ea1c097469_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/287b6598-2122-412a-b0e3-7a072778b1e7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","rdfs:label":"ID# 136","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"phenotypeFreeText":"short stature; \"severe\" biventricular hypertrophy; supraventricular tachycardia; ventricular septal defect; failure to thrive in infancy; generalized hypotonia; hepatoblastoma","previousTesting":true,"previousTestingDescription":"DNA from father unavailable","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/08184684-12d9-4e7b-a69f-93ea1c097469_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA280036"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38a8b046-e1e2-45d2-8cac-62260ea04c9d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"absent from gnomAD w/ functional evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4efdf18-bbba-4e4a-9869-b5f2717667f4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","rdfs:label":"N.2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"phenotypeFreeText":"polyhydramnios; short stature; macrocephaly; failure to thrive; sparse eyebrow; downslanted palpebral fissures; hypertelorism; ptosis; low-set ears; thickened helices; large earlobe; depressed nasal bridge; thick vermilion border; wide mouth; micrognathia; pulmonic stenosis; sinus tachycardia; sparse hair; curly hair; short neck; webbed neck; pectus carinatum; global developmental delay; generalized hypotonia","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/38a8b046-e1e2-45d2-8cac-62260ea04c9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/23afffe4-8f12-47de-a22b-79cf9857ed37_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5c46e1f-d2e0-458e-a7d1-bf17fed2f9e3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","rdfs:label":"N.4","ageType":"AgeAtReport","ageUnit":"Years","phenotypeFreeText":"polyhydramnios; large for gestational age; macrocephaly; sparse eyebrow; downslanted palpebral fissures; hypertelorism; epicanthus; ptosis; low-set ears; thickened helices; large earlobe; depressed nasal bridge; long philtrum; deep philtrum; micrognathia; anomalous pulmonary venous return; curly hair; short neck; webbed neck; pectus excavatum; cubitus valgus; generalized hypotonia","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/23afffe4-8f12-47de-a22b-79cf9857ed37_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3de8743-a73d-479c-b9fc-2d17cf10a687","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.388T>C (p.Tyr130His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279999"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3a8f6317-2f7f-4500-b083-edc41c459ab7_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ca5eb18-e7d5-49df-ad75-e1ea7e94d027","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","rdfs:label":"N.3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"phenotypeFreeText":"large for gestational age; short stature; macrocephaly; failure to thrive; sparse eyebrow; downslanted palpebral fissures; hypertelorism; epicanthus; ptosis; low-set ears; thickened helices; large earlobe; depressed nasal bridge; long philtrum; deep philtrum; cavernous hemangioma; nevus; curly hair; short neck; webbed neck; pectus excavatum; \"joint limitations/hyperextension\"; cubitus valgus; global developmental delay; generalized hypotonia; astigmatism","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3a8f6317-2f7f-4500-b083-edc41c459ab7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5218f0b0-e92b-4dbe-b1a4-27b43d5eaa0f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 23 CFC patients for variants in BRAF, MAP2K1 and MAP2K2 using bidirectional sequencing. They identified 2 MAP2K1 variants in 2 individuals, both of which were shown to be de novo. The authors did not provide a lot of specific phenotypic information. Explanations of the abnormalities described are found in Table S1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a688c5d-ffa1-428d-840c-a664cba24bf6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16439621","rdfs:label":"CFC Individual 20","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"phenotypeFreeText":"abnormal facial shape; curly hair; hyperkeratosis; hyperkeratosis pilaris; numerous nevi; hemangioma; \"mild\" pulmonic stenosis; \"mild\" pectus excavatum; hypoplasia of the corpus callosum","phenotypes":["obo:HP_0002212","obo:HP_0001999","obo:HP_0001028","obo:HP_0000962","obo:HP_0040180","obo:HP_0002079","obo:HP_0000767","obo:HP_0001642","obo:HP_0001054"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5218f0b0-e92b-4dbe-b1a4-27b43d5eaa0f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16439621","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5375fc97-1eda-485f-86dc-fdd42975ebdb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 33 CFC patients for variants in MAP2K1 and MAP2K2 using DHPLC confirmed by dye terminator sequencing. They identified 3 variants in 4 individuals, all of which were show to occur de novo. This variant was absent from gnomAD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26df137b-b814-42f5-8253-bbfde7957f68","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","rdfs:label":"N.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"detectionMethod":"This study screened 33 CFC patients for variants in MAP2K1 and MAP2K2 using DHPLC confirmed by dye terminator sequencing. They identified 3 variants in 4 individuals, all of which were show to occur de novo.","phenotypeFreeText":"polyhydramnios; short stature; macrocephaly; failure to thrive; sparse eyebrow; downslanted palpebral fissures; hypertelorism; epicanthus; ptosis; low-set ears; thickened helices; depressed nasal bridge; thick vermilion border; wide mouth; micrognathia; pulmonic stenosis; multiple cafe-au-lait spots; sparse hair; curly hair; short neck; webbed neck; global developmental delay; generalized hypotonia","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5375fc97-1eda-485f-86dc-fdd42975ebdb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19156172","allele":{"id":"https://genegraph.clinicalgenome.org/r/83f12af8-ac1f-4748-9b4d-3207ed2aa2c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.124C>T (p.Leu42Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/44587"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/651ec06f-ab4a-4f39-b254-f5c96484733c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aef289be-bda2-48ee-b548-30dd728447be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","rdfs:label":"ID# 163","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"phenotypeFreeText":"short stature; pulmonic stenosis; polyhydramnios; failure to thrive in infancy; generalized hypotonia; papilloma \"resolved; curly hair; \"ulnar deviation\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/651ec06f-ab4a-4f39-b254-f5c96484733c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e094c819-d52d-4216-bb15-64d2d8be63ef_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1d2a0df-60f1-44ce-8543-09672c6dab1f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","rdfs:label":"ID# 146","phenotypeFreeText":"short stature; failure to thrive in infancy; generalized hypotonia; hypoplasia of the corpus callosum; hyperkeratosis; \"perianal\" papilloma","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e094c819-d52d-4216-bb15-64d2d8be63ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c565e89-c2ca-4d27-8405-2334aa13bce5"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f511c9c9-f657-4c71-b998-f898844d08c6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 23 CFC patients for variants in BRAF, MAP2K1 and MAP2K2 using bidirectional sequencing. They identified 2 MAP2K1 variants in 2 individuals, both of which were shown to be de novo. The authors did not provide a lot of specific phenotypic information. Explanations of the abnormalities described are found in Table S1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03ba0ce1-36f3-4f78-be48-e534ee839d55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16439621","rdfs:label":"CFC Individual 19","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"detectionMethod":"This study screened 23 CFC patients for variants in BRAF, MAP2K1 and MAP2K2 using bidirectional sequencing. They identified 2 MAP2K1 variants in 2 individuals, both of which were shown to be de novo. The authors did not provide a lot of specific phenotypic information. Explanations of the abnormalities described are found in Table S1.","firstTestingMethod":"PCR","phenotypeFreeText":"abnormal facial shape; curly hair; hyperkeratosis; hyperkeratosis pilaris; numerous nevi; pulmonic stenosis; hypertrophic cardiomyopathy; failure to thrive; scoliosis; pectus excavatum; generalized bone demineralization; nystagmus; cerebral atrophy; seizures; severe global developmental delay; \"prominence of the lateral ventricles\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f511c9c9-f657-4c71-b998-f898844d08c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16439621","allele":{"id":"https://genegraph.clinicalgenome.org/r/1362504c-8419-4cf1-9891-d4b7efada037","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.158T>C (p.Phe53Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279966"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/52ec473b-27a2-4343-a8cf-1855225f0dce_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d78429d-4078-4498-929d-b2af23b5b2be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","rdfs:label":"ID# 95","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":7,"phenotypeFreeText":"atrial septal defect; ventricular septal defect; pulmonic stenosis; failure to thrive in infancy; generalized hypotonia; alopecia; skin rash; sparse eyebrow; sparse hair; delayed myelination","phenotypes":["obo:HP_0000988","obo:HP_0001596","obo:HP_0045075","obo:HP_0008070","obo:HP_0001290","obo:HP_0001629","obo:HP_0001642","obo:HP_0001531","obo:HP_0001631","obo:HP_0012448"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/52ec473b-27a2-4343-a8cf-1855225f0dce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","allele":{"id":"https://genegraph.clinicalgenome.org/r/33601bc0-462e-4390-b07e-6472f970e13d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16602250"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/6b235b7c-ca63-4e21-b1a6-ced60c1336b8_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df680fa8-3317-491e-8add-72116827778f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","rdfs:label":"ID# 144","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"phenotypeFreeText":"short stature; hypertrophic cardiomyopathy; polyhydramnios; failure to thrive in infancy; strabismus; deep palmar crease; deep plantar crease; \"perianal\" papilloma; hypertension; elevated urinary vanillymandelic acid; elevated urinary homovanillic acid; coarse facial features; severe global developmental delay; hydrocephalus; sparse eyebrow","phenotypes":["obo:HP_0001869","obo:HP_0006191","obo:HP_0011978","obo:HP_0000486","obo:HP_0001531","obo:HP_0000822","obo:HP_0045075","obo:HP_0001639","obo:HP_0011977","obo:HP_0012740","obo:HP_0000238","obo:HP_0001561","obo:HP_0004322","obo:HP_0011344","obo:HP_0000280"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6b235b7c-ca63-4e21-b1a6-ced60c1336b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17551924","allele":{"id":"https://genegraph.clinicalgenome.org/r/0103f9b3-4929-4fd8-9f32-400fc72e415f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002755.4(MAP2K1):c.175_177del (p.Lys59del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/222074"}}}}],"specifiedBy":"GeneValidityUncategorizedProbandCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23fa6754-9e0a-479a-b1b2-5f35ea28376a","type":"EvidenceLine","dc:description":"MAP2K1 is found in the RAS/MAPK pathway which is associated with RASopathies, and CFC","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82292910-3d8f-40d2-9af6-724ba7ef02c6","type":"Finding","dc:description":"MAP2K1 is found in the RAS/MAPK pathway","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23875798","rdfs:label":"MAP2K1 RAS/MAPK Pathway","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f8c7a090-0a97-4653-bd51-702a9f9144b9_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34d1eea9-38c0-4719-9cff-87abf5f32059","type":"EvidenceLine","dc:description":"only implicates the gene with RASopathies, doesn't provide specific evidence indicating that the gene only causes CFC.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67d5ad1c-5014-4803-9a75-bfb44a527ec2","type":"FunctionalAlteration","dc:description":"The variant led to constitutive ERK activation compared to WT. (ORIGINALLY FROM THE MAP2K1 NOONAN CURATION, BUT IMPLICATES MAP2K1 WITH RASOPATHY)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25049390","rdfs:label":"p.Asp67Asn varaint"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b96cab87-d5db-4a1e-9ec6-958d04cdf3d2","type":"EvidenceLine","dc:description":"Does not implicate CFC specifically, only pathogenicity of variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2ac8caa-c143-4663-881a-c68a4ba63c04","type":"FunctionalAlteration","dc:description":"Both variants led to an increase in ERK phosphorylation compared to WT.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18413255","rdfs:label":"F53S and Y130C variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6eb622c9-500f-447f-ab6e-2cab5ff14887","type":"EvidenceLine","dc:description":"Doesn't specifically implicate CFC","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7df4bf3-d207-4531-b6bc-418a4e6ab189","type":"FunctionalAlteration","dc:description":"Both variants increased ERK/MAPK activity in the presence of EGF but not in a starved state. This activation was dependent upon the phosphorylation of S218 and S222. The effect of both variants was inhibited by an MEK inhibitor. Found that F53C MEK1 and Y134C MEK2 mutants require RAF signals to activate ERK1/2.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17981815","rdfs:label":"F53S and Y130C variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Definitive","sequence":2323,"specifiedBy":"GeneValidityCriteria5","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/-w0nNtHh_0Y","type":"GeneValidityProposition","disease":"obo:MONDO_0015280","gene":"hgnc:6840","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f8c7a090-0a97-4653-bd51-702a9f9144b9-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}